Biogen | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
AbbVie USD 700M 90M 2025-03
Acadia Pharmaceuticals 0 4.12M 2024-09
ALKERMES USD 0 0 2025-06
Amgen USD 694M 29M 2025-06
Bayer 495M 89M 2025-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Eli Lilly USD 249M 5.3M 2025-06
Gilead Sciences USD 254M 6M 2025-06
Incyte USD 594K 66K 2025-06
Merck USD 305M 8M 2025-06
Moderna USD 1000K 0 2025-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 289M 19M 2025-06
Pfizer USD 654M 0 2025-06
PTC Therapeutics USD 30.36M 4.03M 2025-06
Regeneron Pharmaceuticals USD 3.6M 5.1M 2025-06
Sanofi 148M 65M 2025-06
Sanofi 66.11M 20.67M 2024-12
Sarepta Therapeutics USD 5.23M 725K 2025-06
Teva Pharmaceutical Industries USD 252M 40M 2025-06
Ultragenyx Pharmaceutical 14.04M 1.48M 2025-06
United Therapeutics USD 7.3M 1.2M 2025-06
Vertex Pharmaceuticals USD 3.7M 900K 2025-06


Biogen Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.